The emergence of therapeutic agents like semaglutide and tirzepatide has significantly altered the approach to managing type 2 diabetes and achieving weight reduction. While both drugs share a similar mechanism of action – mimicking the effects of the natural hormone GLP-1 – tirzepatide possesses a unique advantage: it’s a dual agonist, targe